Biotricity, Inc. (BTCY) | Stock price, performance, AI analysis | Thematic | AI powered fundamental research and development platform

Loading...

Research a topic Stock screener Find companies

Search for securities Load an existing portfolio Backtest

How to use About us Blog

|

Research a topic Stock screener Find companies

Search for securities Load an existing portfolio Backtest

How to use About us Blog

Follow our journey and product updates

Product

Research a topic Stock screener Find companies Search for securities Load an existing portfolio Backtest

Learn

Thematic overview Develop asset-backed products Company evaluations Backtesting and benchmarking Thematic branded indices Build investment strategies with crypto

Company

How to use About us Blog

Team Research

There is currently no saved research for this page.

Biotricity, Inc. (BTCY)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation

Company performance

Add to research

Current Price

as of Apr 21, 2025

$0.43

P/E Ratio

N/A

Market Cap

$10.71M

Description

Add to research

Biotricity, Inc. is a medical technology company, which engages in biometric data monitoring solutions. It operates through the following segments: Resting (Non-stress) ECG Systems, Stress ECG Systems, and Holter Monitoring Systems. The company was founded by Waqaas Al-Siddiq and Peter McGoldrick on August 29, 2012 and is headquartered in Redwood City, CA.

Metrics

Add to research

Overview

HQRedwood City, CA
SectorTechnology Services
IndustryPackaged Software
TickerBTCY
Price$0.43+2.38%

Trading Information

Market cap$10.71M
Float57.43%
Average Daily Volume (1m)31,718
Average Daily Volume (3m)34,125
EPS-$1.08

Company

Revenue$13.27M
Rev growth (1yr)21.73%
Net income-$1.23M
Gross margin76.37%
EBITDA margin-4.63%
EBITDA-$0.17M

EV$34.11M
EV/Revenue2.57
P/EN/A
P/S0.79
P/BN/A
Debt/EquityN/A

Documents

Add to research

SEC Filings

8-K (2025-02-24)

8-K (2024-11-20)

8-K (2024-08-16)

8-K (2024-08-07)

8-K (2024-08-01)

8-K (2024-07-16)

8-K (2024-07-12)

8-K (2024-06-24)

8-K (2024-06-07)

8-K (2024-05-28)

8-K (2024-05-21)

8-K (2024-05-03)

8-K (2024-04-23)

8-K (2024-04-03)

8-K (2024-03-26)

8-K (2024-02-02)

8-K (2023-11-06)

8-K (2023-09-20)

8-K (2023-08-17)

8-K (2023-08-04)

8-K (2023-07-20)

8-K (2023-07-05)

8-K (2023-05-18)

8-K (2023-04-03)

8-K (2023-01-27)

8-K (2023-01-20)

10-Q (2025-02-19)

10-Q (2024-11-14)

10-Q (2024-08-19)

10-Q (2024-02-20)

10-Q (2023-11-14)

10-Q (2023-08-14)

10-Q (2023-02-14)

10-K (2024-06-27)

10-K (2023-06-29)

Factset Street Account

Biotricity reports Q2 EPS ($0.44) vs year-ago ($0.57) ($0.90, 0.00) (2023-11-14T21:36:52Z)

Biotricity files patent application for Biotres device ($2.13, 0.00) (2023-10-03T12:34:46Z)

Biotricity enters into subscription agreement with an investor and issues a $1M unsecured convertible preferred note - 8-K ($0.95, 0.00) (2023-11-06T22:13:30Z)

Biotricity downgraded to neutral from buy at HC Wainwright ($0.99, 0.00) (2023-11-20T11:03:55Z)

Earnings Calls

Earnings Report 2025Q2

Earnings Report 2024Q4

Earnings Report 2024Q3

Earnings Report (2023-11-14)

Earnings Report (2023-08-15)

Factset

Factset Business Description

Ask a question

New feature

Thematic Research

View all of your research in one place. Toggle open the floating actions menu and click Open research sidebar to view your saved research for the current page.